Ir al contenido
  • Company
    • Overview
    • Company mission vision and objectives
    • Team
  • Drug Delivery Platforms
    • Proprietary Technologies
    • NANO-GES
    • SANP
    • MUCO-LAST
  • Products
    • Hair loss
    • Nail infections
    • Mucosal vaccines
    • Cosmetics
    • Mucosal treatments
    • Topical drug delivery
  • Services
    • Overview
    • Assay and Quality Control (QC)
    • Preformulation development and screening
    • Preformulation, formulation design and optimization
    • Final product design and GMP Manufacturing
    • Process and semi-industrialization
    • Formulations and designs
    • Franz diffusion cells
  • Joint Projects
  • News
  • Contact
  • Company
    • Overview
    • Company mission vision and objectives
    • Team
  • Drug Delivery Platforms
    • Proprietary Technologies
    • NANO-GES
    • SANP
    • MUCO-LAST
  • Products
    • Hair loss
    • Nail infections
    • Mucosal vaccines
    • Cosmetics
    • Mucosal treatments
    • Topical drug delivery
  • Services
    • Overview
    • Assay and Quality Control (QC)
    • Preformulation development and screening
    • Preformulation, formulation design and optimization
    • Final product design and GMP Manufacturing
    • Process and semi-industrialization
    • Formulations and designs
    • Franz diffusion cells
  • Joint Projects
  • News
  • Contact
  • Company
    • Overview
    • Company mission vision and objectives
    • Team
  • Drug Delivery Platforms
    • Proprietary Technologies
    • NANO-GES
    • SANP
    • MUCO-LAST
  • Products
    • Hair loss
    • Nail infections
    • Mucosal vaccines
    • Cosmetics
    • Mucosal treatments
    • Topical drug delivery
  • Services
    • Overview
    • Assay and Quality Control (QC)
    • Preformulation development and screening
    • Preformulation, formulation design and optimization
    • Final product design and GMP Manufacturing
    • Process and semi-industrialization
    • Formulations and designs
    • Franz diffusion cells
  • Joint Projects
  • News
  • Contact
  • Company
    • Overview
    • Company mission vision and objectives
    • Team
  • Drug Delivery Platforms
    • Proprietary Technologies
    • NANO-GES
    • SANP
    • MUCO-LAST
  • Products
    • Hair loss
    • Nail infections
    • Mucosal vaccines
    • Cosmetics
    • Mucosal treatments
    • Topical drug delivery
  • Services
    • Overview
    • Assay and Quality Control (QC)
    • Preformulation development and screening
    • Preformulation, formulation design and optimization
    • Final product design and GMP Manufacturing
    • Process and semi-industrialization
    • Formulations and designs
    • Franz diffusion cells
  • Joint Projects
  • News
  • Contact

Bionanoplus participates in BioSpain2025

octubre 9, 2025

Bionanoplus had the pleasure of participating in Biospain 2025, held on October 7, 8, and 9 in Barcelona. It was a very enriching experience to

Leer más »

Bionanoplus joins the ‘Navarra Health Cluster’

mayo 21, 2025

Bionanoplus joins the ‘Navarra Health Cluster’, an association that brings together companies, knowledge centers and public and private institutions working in the field of health

Leer más »

Bionanoplus held the final meeting of the ASINA project in Castelbrando (Italy).

junio 18, 2024

On February 2024, the European consortium met to analyze and discuss the results of the research that aimed to promote the safe use of nanotechnology

Leer más »

Emilia Chuina Tomazeli defends her thesis entitled ‘Isolation of a new Tuber borchii strain and characterization of its transcriptomics and volatile compounds profile in vitro cultures’.

junio 18, 2024

Last February 9th, our colleague Emilia Chuina Tomazeli defended her PhD thesis entitled ‘Isolation of a new Tuber borchii and characterization of its transcriptomics and

Leer más »

Emilia Chuina Tomazeli and Bionanoplus published the Transcriptome Metabolic Characterization of Tuber Borchii SP1

junio 18, 2024

On July 2023, during the course of her industrial phD at Bionanoplus, Emilia has satisfactorily completed the Transcriptome Metabolic Characterization of Tuber Borchii SP1 –

Leer más »

One of Bionanoplus’ technologies key for pest control and real time insect detection in agriculture

agosto 29, 2017

The initiative, in collaboration with the SME AgroPest Alert has obtained the maximum rating in the Government of Navarre call for Research and Development projects for

Leer más »

The Navarrese company Bionanoplus comes to the market hand in hand with the pharmaceutical group IFC.

marzo 15, 2017

The product, the result of close collaboration, is based on the innovative patented technology of Bionanoplus in order to provide a renewed treatment for moderate

Leer más »

The European Commission grants a project to Bionanoplus to develop a veterinary vaccine as part of the “SME Instrument” program

junio 10, 2016

This project (SAP-Nano) is based on the application of a patented technology, versatile and easy to scale up in order to encapsulate antigens and develop

Leer más »

Bionanoplus will participate in a major European Project that will explore an innovative and sustainable in situ self-assembly nanoencapsulation technology to deliver novel products for skin healthcare applications

julio 1, 2015

Bionanolus will participate in the European research project SKHINCAPS (SKin Healthcare by Innovative NanoCAPsuleS), financed by the European Union Horizon 2020 Programme (H2020). The consortium

Leer más »

The Spanish Biotech sector will have a place in the radio

mayo 26, 2015

RNE, National Radio of Spain, and ASEBIO, The Spanish Association of Biotech Companies, have sign this week and agreement to spread and promote biotech in

Leer más »